Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

Fig. 1

The global disease burden of NASH-related liver cancer attributable to HFPG for different age groups. A The deaths number of NASH-related liver cancer attributable to HFPG for different age group in 1990 and 2019; B The ASMR of NASH-related liver cancer attributable to HFPG for different age group in 1990 and 2019; C The DALYs number of NASH-related liver cancer attributable to HFPG for different age group in 1990 and 2019; D The ASDR of NASH-related liver cancer attributable to HFPG for different age group in 1990 and 2019. NASH: nonalcoholic steatohepatitis; ASMR, age-standardized mortality rate; DALYs, disability adjusted life years; ASDR, age-standardized DALYs rate; SDI: socio-demographic index; EPAC: estimated annual percentage changes

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us